Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study. - Wikidata - wikimedia - TriplyDB

Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study.

Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study.

http://www.wikidata.org/entity/Q47755175

about

Polyunsaturated fatty acid metabolism in prostate cancer 3' end mRNA processing: molecular mechanisms and implications for health and disease Molecular pathology of prostate cancer Mechanisms of omega-3 polyunsaturated fatty acids in prostate cancer prevention Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer.Toll-like receptor signaling pathway variants and prostate cancer mortality.Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies Cholesterol and benign prostate disease.The regulatory toll-like receptor 4 genetic polymorphism rs11536889 is associated with renal, coagulation and hepatic organ failure in sepsis patients.Polymorphism of NLRP3 Gene and Association with Susceptibility to Digestive Disorders in Rabbit Single nucleotide polymorphisms of Toll-like receptor 4 decrease the risk of development of hepatocellular carcinoma.Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer.A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L.The association of Toll-like receptor 4 gene polymorphisms with the development of emphysema in Japanese subjects: a case control study Cancer and inflammation: promise for biologic therapy.A multigenic approach to evaluating prostate cancer risk in a systematic replication study.Polymorphisms of an innate immune gene, toll-like receptor 4, and aggressive prostate cancer risk: a systematic review and meta-analysis.Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II.Association of the innate immunity and inflammation pathway with advanced prostate cancer risk.Association of Toll-like receptor polymorphisms with HIV status in North Americans The role of TLR2, TLR4 and CD14 genetic polymorphisms in gastric carcinogenesis: a case-control study and meta-analysis.Peroxiredoxin 1 controls prostate cancer growth through Toll-like receptor 4-dependent regulation of tumor vasculature Association of TLR2 and TLR4 polymorphisms with risk of cancer: a meta-analysis.Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality.Mechanisms and pathways of innate immune activation and regulation in health and cancer.Agents in development for prostate cancer prevention.A single nucleotide polymorphism in 3'-untranslated region contributes to the regulation of Toll-like receptor 4 translation.n-3 Polyunsaturated Fatty Acids and their Role in Cancer Chemoprevention.Links between Propionibacterium acnes and prostate cancer.Prospective study of effect modification by Toll-like receptor 4 variation on the association between Trichomonas vaginalis serostatus and prostate cancer.Inflammation in prostate carcinogenesis.Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword?Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk.TLR agonists: our best frenemy in cancer immunotherapy Toll-like receptors in the gonads and reproductive tract: emerging roles in reproductive physiology and pathology.TLR3 and TLR4 expression in healthy and diseased human endometrium.The role of inflammation and infection in the pathogenesis of prostate carcinoma.Constitutional polymorphisms of prostate cancer: prognostic and diagnostic implications.

P2860

Q24629893-5A5D44B7-0371-450F-B574-713ADCBEE8B9 Q24648650-073A4270-3CDD-4651-8A98-4B036DDA1147 Q24672410-8133AE28-E611-4BCC-BAEC-E77EA721BF2D Q26830150-33E7F093-ED27-4622-9B51-A1A369E156FF Q28384157-C35E5370-EBBA-4E31-8FAB-67D4CC53D0D3 Q30855755-6956E520-7216-4FF8-93D6-14EC942B031D Q33708730-C4854530-C9C2-4AF7-B4D8-21CF17CA047C Q33723482-58ADE9CE-0B2B-4BE6-884E-C90DC150E518 Q33732687-30029DAE-63E7-4CF9-986C-2635EC5F8E0C Q33858845-7EE528CD-D85A-469C-8167-ED49D6B10D40 Q33885843-5CC6324A-8A1E-4336-915E-7889A2ACD2F6 Q33894934-723FFCD1-8E26-49F9-B805-1A79251806C7 Q33904205-84617BC3-769F-48A0-ACC6-0FE0BAAA399A Q33990371-F7C76E94-001A-4A7E-9AAF-8F305647FA92 Q34055654-BAE9C129-29DE-46F6-A22B-AD4BF021D4B9 Q34129767-EE06030B-9D6D-4647-AFE9-20D852802CC0 Q34139732-39A2075A-FAC8-4B86-9BE1-92878EC81904 Q34156268-8BBF5C9F-584B-4F81-AC0A-CACD4FD86CA9 Q34434293-0A297FF9-1552-4BA5-95A0-F505B9998D20 Q34470467-36EB4081-D667-4A4D-A3C2-1F86DCF971E5 Q34525515-55B7D75A-854B-4854-96C5-A56CF7F03960 Q34642208-7C12B136-36B1-4DDA-B7A2-6A5AE137F6E2 Q34658328-2107ADFF-19CE-45F2-912B-3308E0FCD438 Q34793013-B337CA63-34DC-46E0-ABCA-92B3D9E1803C Q35077769-39E4429C-DCE5-408C-9C54-0A0963F28EA7 Q35218136-1C33C5C8-C9B9-459A-890B-0740F8F2CDF4 Q35886583-4DC9A532-BFB4-40A3-9656-D184FD76E2A2 Q35964705-7181FD99-8C75-4765-BF63-305088DBB586 Q36127232-B6468CE5-834F-49D5-B224-BC20E1AAB499 Q36131716-B2DDE351-88AE-4088-9C44-EB23ABFE41DA Q36430739-679919FE-7AC2-45B0-960A-FD321CA8F947 Q36546861-2C1861E6-6E08-4A12-86C8-D164172A3D1C Q36554784-BC52F7C4-541A-45F3-9F6D-0B8B09E42A03 Q36557953-34FB65D1-3B04-43A5-959B-D369B82FCA95 Q36615163-B8084756-554C-4378-8346-CB06B22265EE Q36850457-3625F653-C768-426F-BAF1-63C0F7CCDC49 Q36860597-392FAFB8-3CA3-46C9-8770-351E71143516 Q36891382-3F12ACCE-1A4A-4346-A7F1-D765BE2382BB Q36896013-E6BCA799-7929-4CD1-8D33-1ABB1E047F43 Q37016023-653CF1C6-B274-4D9D-84D5-4CC75C5B5A23

P2860

Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study.

http://www.wikidata.org/entity/Q47755175

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Sequence variants of toll-like ...... ncer Prostate in Sweden Study.

@en

Sequence variants of toll-like ...... ncer Prostate in Sweden Study.

@nl

type

label

Sequence variants of toll-like ...... ncer Prostate in Sweden Study.

@en

Sequence variants of toll-like ...... ncer Prostate in Sweden Study.

@nl

prefLabel

Sequence variants of toll-like ...... ncer Prostate in Sweden Study.

@en

Sequence variants of toll-like ...... ncer Prostate in Sweden Study.

@nl

P1433

Q47755175-BFF713C3-D5B5-4134-94D9-83B16B8B18E1

P1476

Q47755175-431470D7-5B7B-454C-ADA2-235D10A5ACF3

P2093

Q47755175-035B0651-4DEA-4F66-AC7B-4CC39A2ED1A9

Q47755175-24F6B28A-3385-4F2A-805C-4095A170DE7A

Q47755175-2C1328F8-D433-415B-9558-F06571A0BFB0

Q47755175-3ABBD06D-EB05-400E-A85B-6B272F62EA0B

Q47755175-6DB2ACFF-FA6E-4ECF-9E53-CE7923EF516C

Q47755175-90DDCC5F-084B-4986-8827-88A722174A19

Q47755175-AEC192E8-B312-45F9-8982-AFABDD72F677

Q47755175-B2B1CFE0-C3F1-437F-8E3E-7EFB26AE7ED6

Q47755175-D77B8EE5-2F11-4394-B1A3-FD337334F863

Q47755175-DBC5F50F-D7E9-4BD8-8D5E-04F1C0F6F2F0

P304

Q47755175-2FDEA32D-2C9E-4812-8719-D1D9C23CBA6E

P31

Q47755175-28DE134C-9C96-40A3-992E-AD96D20E023C

P356

Q47755175-1D1F02FF-DBE9-40A7-B864-790935575956

P407

Q47755175-B918C447-B9F2-4E1D-AAAB-E0B215036055

P433

Q47755175-5E61CBFF-65BE-43CA-A32D-13616B063C7A

P478

Q47755175-0087BBDA-3DBE-4856-A649-D27C71CED9F5

P50

Q47755175-4D2B84C0-6395-4863-9758-B9FD8A009D07

Q47755175-A66B72F2-4FC3-48D3-9757-C482B5E2425E

Q47755175-E34CC195-B262-4E21-89E4-BCEC64D7775D

Q47755175-F25551F0-E79C-4575-83F6-0BB32B610091

P577

Q47755175-6514203F-A06F-46B0-BFB6-C18F09C8468C

P5875

Q47755175-0EA2D6E1-C1BF-47EE-9524-E9ADB576BAF0

P698

Q47755175-9A8BA010-B836-4408-874F-07A7CA6F12D9

P921

Q47755175-B35ED3FC-C1A0-437C-923F-13BA0CF4F4EC

Q47755175-DB242C00-DD19-40DD-8EC0-08BAF312B4F2

P356

0008-5472.CAN-03-3280

P1433

Cancer Research

P1476

Sequence variants of toll-like ...... ncer Prostate in Sweden Study.

@en

P2093

Aubrey R Turner

http://www.w3.org/2001/XMLSchema#string

Baoli Chang

http://www.w3.org/2001/XMLSchema#string

Deborah A Meyers

http://www.w3.org/2001/XMLSchema#string

Ge Li

http://www.w3.org/2001/XMLSchema#string

Jan-Erik Johnasson

http://www.w3.org/2001/XMLSchema#string

Jeanette Bensen

http://www.w3.org/2001/XMLSchema#string

Katarina Augustsson-Bälter

http://www.w3.org/2001/XMLSchema#string

Maria Hedelin

http://www.w3.org/2001/XMLSchema#string

S Lilly Zheng

http://www.w3.org/2001/XMLSchema#string

Tamara S Adams

http://www.w3.org/2001/XMLSchema#string

P304

2918-2922

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-03-3280

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

Henrik Grönberg

Hans-Olov Adami

P577

2004-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8616732

http://www.w3.org/2001/XMLSchema#string

P698

15087412

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor